Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Net Margin (2021 - 2023)

Senti Biosciences has reported Net Margin over the past 3 years, most recently at 6417.75% for Q3 2023.

  • Quarterly results put Net Margin at 6417.75% for Q3 2023, up 657191.0% from a year ago — trailing twelve months through Jun 2024 was 488.17% (up 8114.0% YoY), and the annual figure for FY2025 was 308418.18%, changed.
  • Net Margin for Q3 2023 was 6417.75% at Senti Biosciences, up from 647.31% in the prior quarter.
  • Over the last five years, Net Margin for SNTI hit a ceiling of 6417.75% in Q3 2023 and a floor of 14483.05% in Q4 2022.
  • Median Net Margin over the past 3 years was 1110.36% (2022), compared with a mean of 1585.58%.
  • Biggest five-year swings in Net Margin: tumbled -1328891bps in 2022 and later skyrocketed 657191bps in 2023.
  • Senti Biosciences' Net Margin stood at 1194.14% in 2021, then plummeted by -1113bps to 14483.05% in 2022, then skyrocketed by 144bps to 6417.75% in 2023.
  • The last three reported values for Net Margin were 6417.75% (Q3 2023), 647.31% (Q2 2023), and 378.69% (Q1 2023) per Business Quant data.